Cytori Therapeutics Inc (NASDAQ:CYTX) will post its quarterly earnings results after the market closes on Thursday, August 10th. Analysts expect Cytori Therapeutics to post earnings of ($0.16) per share for the quarter.

Cytori Therapeutics (NASDAQ:CYTX) last announced its earnings results on Thursday, May 11th. The biotechnology company reported ($0.26) EPS for the quarter, beating analysts’ consensus estimates of ($0.31) by $0.05. Cytori Therapeutics had a negative return on equity of 177.92% and a negative net margin of 491.71%. The company had revenue of $0.60 million during the quarter, compared to analysts’ expectations of $2.32 million. During the same period last year, the business posted ($0.03) EPS. Cytori Therapeutics’s revenue for the quarter was down 53.8% on a year-over-year basis. On average, analysts expect Cytori Therapeutics to post $-0.64 EPS for the current fiscal year and $-0.12 EPS for the next fiscal year.

Shares of Cytori Therapeutics Inc (NASDAQ CYTX) traded down 4.87548% during trading on Monday, reaching $0.37051. The company had a trading volume of 67,055 shares. The firm’s market capitalization is $12.03 million. The firm has a 50-day moving average of $0.95 and a 200 day moving average of $1.27. Cytori Therapeutics Inc has a 52 week low of $0.36 and a 52 week high of $2.29.

Several brokerages have commented on CYTX. ValuEngine upgraded Cytori Therapeutics from a “strong sell” rating to a “sell” rating in a research note on Thursday, July 13th. Zacks Investment Research lowered Cytori Therapeutics from a “buy” rating to a “hold” rating in a research note on Wednesday, July 12th. Maxim Group set a $10.00 price target on Cytori Therapeutics and gave the stock a “buy” rating in a research note on Monday, July 10th. Finally, B. Riley restated a “buy” rating and set a $2.30 price target on shares of Cytori Therapeutics in a research note on Monday, May 15th.

ILLEGAL ACTIVITY NOTICE: “Cytori Therapeutics Inc (CYTX) Scheduled to Post Earnings on Thursday” was originally published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The legal version of this report can be accessed at

Cytori Therapeutics Company Profile

Cytori Therapeutics, Inc (Cytori) is a biotechnology company engaged in the development of treatments and devices for a range of disorders using cells as a key part of the therapy. The Company develops cellular therapeutics formulated and optimized for specific diseases and medical conditions and related products.

Earnings History for Cytori Therapeutics (NASDAQ:CYTX)

Receive News & Ratings for Cytori Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cytori Therapeutics Inc and related companies with's FREE daily email newsletter.